Advertisement

Pharmaceutical Research

, Volume 23, Issue 1, pp 184–195 | Cite as

Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy

  • S. Hariharan
  • V. Bhardwaj
  • I. Bala
  • J. Sitterberg
  • U. Bakowsky
  • M. N. V. Ravi Kumar
Research Paper

Abstract

Estradiol (E2), a highly lipophilic molecule with good oral absorption but poor oral bioavailability, was incorporated into poly(lactide-co-glycolide) (PLGA) nanoparticles to improve its oral bioavailability. Nanoparticles were prepared by using polyvinyl alcohol (PVA) or didodecyldimethylammonium bromide (DMAB) as stabilizer, leading to negatively (size 410.9 ± 39.4 nm) and positively (size 148.3 ± 10.7 nm) charged particles, respectively. Both preparations showed near zero order release in vitro with about 95% drug being released within 45 and 31 days for PVA and DMAB, respectively. In situ intestinal uptake studies in male Sprague–Dawley (SD) rats showed higher uptake of DMAB stabilized nanoparticles. Following oral administration to male SD rats, E2 could be detected in blood for 7 and 2 days from DMAB and PVA stabilized nanoparticles, respectively. Histopathological examination and blood counts indicated the absence of inflammatory response. These data suggest that DMAB stabilized PLGA nanoparticles have great potential as carriers for oral delivery of estradiol.

Key Words

absorption blood levels DMAB estradiol nanoparticles oral administration PLGA PVA 

Notes

Acknowledgments

I.B. and S.H. acknowledge NIPER Fellowships in 2003–2005. V.B. is grateful to NIPER for providing PhD Fellowship. Start-up fund from NIPER, Research grants from Royal Society of Chemistry (RSC), London, UK; Third World Academy of Science (TWAS), Italy, and Department of Science and Technology (DST), India, to M.N.V.R.K. are gratefully acknowledged. We take this opportunity to extend our sincere thanks to Orion Pharma (Finland) and Boehringer Ingelheim (Germany) for providing Estradiol and PLGA as gift samples, respectively. Thanks are due to Rahul and Dinesh for providing the technical assistance to this project.

References

  1. 1.
    Djakovic-Sekulic, T., Mackanski, , Persic-Janjic, N. 2001Evaluation of the predictive power of calculation procedure for molecular hydrophobicity of some estradiol derivativesJ. Chromatogr. B7666775Google Scholar
  2. 2.
    Deady, J. 2004Clinical monograph: hormone replacement therapyJ. Manag. Care Pharm.10544557Google Scholar
  3. 3.
    Pazol, K., Kaplan, J. R., Abbott, D., Appt, S. E., Wilson, M. E. 2004Practical measurement of total and bioavailable estradiol in female macaquesClin. Chim. Acta340117126CrossRefPubMedGoogle Scholar
  4. 4.
    Ramachandran, C., Fleisher, D. 2000Transdermal delivery of drugs for the treatment of bone diseasesAdv. Drug Deliv. Rev.42197223CrossRefPubMedGoogle Scholar
  5. 5.
    Rajkumar, L., Guzman, R. C., Yang, J., Thordarson, G., Talamantes, F.,  et al. 2004Prevention of mammary carcinogenesis by short term estrogen and progestin treatmentsBreast Cancer Res.63137CrossRefGoogle Scholar
  6. 6.
    Woolfson, A. D., Elliott, G. R. E., Gillian, C. A., Passmore, C. M. 1999Design of an intravaginal ring for controlled delivery of 17 β-estradiol as its 3-acetate esterJ. Control. Release61319328CrossRefPubMedGoogle Scholar
  7. 7.
    Allemann, E., Leroux, J.-C., Gurny, R. 1998Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimeticsAdv. Drug Deliv. Rev.34171189CrossRefPubMedGoogle Scholar
  8. 8.
    Arbos, P., Campanero, M. A., Arangoa, M. A., Renedo, M. J., Irache, J. M. 2003Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive propertiesJ. Control. Release891930PubMedGoogle Scholar
  9. 9.
    Hans, M. L., Lowman, A. M. 2002Biodegradable nanoparticles for drug delivery and targetingCurr. Opin. Solid State Mater. Sci.6319327Google Scholar
  10. 10.
    Feng, S. S., Mu, L., Win, K. Y., Huang, G. 2004Nanoparticles of biodegradable polymers for clinical administration of paclitaxelCurr. Med. Chem.11413424CrossRefPubMedGoogle Scholar
  11. 11.
    Murakami, H., Kawashima, Y., Niwa, T., Hino, T., Takeuchi, H.,  et al. 1997Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(-lactide-co-glycolide) nanoparticlesInt. J. Pharm.1494349CrossRefGoogle Scholar
  12. 12.
    Jain, R. A. 2000The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials2124752490CrossRefPubMedGoogle Scholar
  13. 13.
    Kumar, M. N. V. R., Bakowsky, U., Lehr, C. M. 2004Preparation and characterization of cationic PLGA nanospheres as DNA carriersBiomaterials2517711777Google Scholar
  14. 14.
    M.-F. Ritz, P. Schmidt, and A. Mendelowitsch. 17β- Estradiol effect on the extracellular concentration of amino acids in the glutamate excitotoxicity model in the rat. Neurochemical Research 27, (2002).Google Scholar
  15. 15.
    Sahoo, S. K., Panyam, J., Prabha, S., Labhasetwar, V. 2002Residual polyvinyl alcohol associated with poly(lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJ. Control. Release82105114CrossRefPubMedGoogle Scholar
  16. 16.
    Kumar, M. N. V. R., Mahopatra, S. S., Kong, X., Jena, P. K., Bakowsky, U.,  et al. 2004Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agentsJ. Nanosci. Nanotechnol.4990994CrossRefPubMedGoogle Scholar
  17. 17.
    Song, C., Zhu, Z., Yang, J., Sun, H., Leng, X.,  et al. 2000Uptake of drug-containing nanoparticles in dog carotid and femoral arteriesZhongguo Yixue Kexueyuan Xuebao22440443PubMedGoogle Scholar
  18. 18.
    Michalowski, C. B., Guterres, S. S., Costa, T. D. 2004Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticlesJ. Pharm. Biomed. Anal.3510931100CrossRefPubMedGoogle Scholar
  19. 19.
    Vandervoort, J., Ludwig, A. 2002Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design studyInt. J. Pharm.2387792CrossRefPubMedGoogle Scholar
  20. 20.
    Quintanar-Guerrero, D., Fessi, H., Allemann, E., Doelker, E. 1996Influence of stabilizing agents and preparative variables on the formation of poly(-lactic acid) nanoparticles by an emulsification–diffusion techniqueInt. J. Pharm.143133141CrossRefGoogle Scholar
  21. 21.
    Blau, S., Jubeh, T. T., Haupt, S. M., Rubinstein, A. 2000Drug targeting by surface cationizationCrit. Rev. Ther. Drug Carr. Syst.17425465Google Scholar
  22. 22.
    El-Shabouri, M. H. 2002Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-AInt. J. Pharm.249101108CrossRefPubMedGoogle Scholar
  23. 23.
    Govender, T., Stolnik, S., Garnett, M. C., Illum, L., Davis, S. S. 1999PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drugJ. Control. Release57171185CrossRefPubMedGoogle Scholar
  24. 24.
    Norris, D. A., Puri, N., Sinko, P. J. 1998The effect of physical barriers and properties on the oral absorption of particulatesAdv. Drug Deliv. Rev.34135154CrossRefPubMedGoogle Scholar
  25. 25.
    Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S.,  et al. 2003Polymer degradation and in vitro release of a model protein from poly(lactide-co-glycolide) nano- and microparticlesJ. Control. Release92173187CrossRefPubMedGoogle Scholar
  26. 26.
    Birnbaum, D. T., Kosmala, J. D., Henthorn, D. B., Brannon-Peppas, L. 2000Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and releaseJ. Control. Release65375387CrossRefPubMedGoogle Scholar
  27. 27.
    Otsuka, M., Udenodan, H., Matsuda, Y., Mogi, T., Ohsima, H.,  et al. 2002Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co- glycolide) microspheres on bone mineral density of osteoporosis ratsBiomed. Mater. Eng.12157167PubMedGoogle Scholar
  28. 28.
    Resetarits, D. E., Cheng, K. C., Bolton, B. A., Prasad, P. N., Shefter, E.,  et al. 1979Dissolution behavior of 17-estradiol (E2) from povidone coprecipitates: comparison with microcrystalline and macrocrystalline E2Int. J. Pharm.2113123CrossRefGoogle Scholar
  29. 29.
    Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., Amidon, G. L. 1997The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependentPharm. Res.1415681573CrossRefPubMedGoogle Scholar
  30. 30.
    Lamprecht, A., Schafer, U., Lehr, C. M. 2001Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosaPharm. Res.18788793CrossRefPubMedGoogle Scholar
  31. 31.
    Fasano, A. 1998Novel approaches for oral delivery of macromoleculesJ. Pharm. Sci.8713511355CrossRefPubMedGoogle Scholar
  32. 32.
    Gutierro, I., Hernandez, R. M., Igartua, A. R., Gascon, A. R., Pedraz, J. L. 2002Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheresVaccine216777CrossRefPubMedGoogle Scholar
  33. 33.
    Sandor, M., Harris, J., Mathiowitz, E. 2002A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivoBiomaterials2344134423CrossRefPubMedGoogle Scholar
  34. 34.
    Cai, Q., Shi, G., Bei, J., Wang, S. 2003Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsinBiomaterials24629638PubMedGoogle Scholar
  35. 35.
    Verdun, C., Brasseur, F., Vranckx, H., Couveur, P., Roland, M. 1990Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticlesCancer Chemother. Pharmacol.261318PubMedGoogle Scholar
  36. 36.
    Maassen, S., Fattal, E., Muller, R., Couvreur, P. 1993Cell cultures for the assessment of toxicity and uptake of polymeric drug carriersSTP Pharma Sci.31122Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • S. Hariharan
    • 1
  • V. Bhardwaj
    • 1
  • I. Bala
    • 1
  • J. Sitterberg
    • 2
  • U. Bakowsky
    • 2
  • M. N. V. Ravi Kumar
    • 1
  1. 1.Department of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER)India
  2. 2.Institute for Pharmaceutical Technology and BiopharmacyPhilipps Universität MarburgMarburgGermany

Personalised recommendations